Get more information on High Throughput Screening Market - Request Sample Report
The High Throughput Screening (HTS) Market Size was valued at USD 25.80 billion in 2023 and is witnessed to reach USD 69.46 Billion by 2032 and grow at a CAGR of 12.18% over the forecast period 2024-2032.
The market for high-throughput screening (HTS) is buoyant because of a unique interplay between forces that are transforming the drug discovery landscape. Pharmaceutical and biotechnology industries are the frontrunners in this scenario where HTS plays a crucial role in quickly filtering libraries of potential drug candidates. This shortens the amount of time required to identify promising leads and thus drives forward new, patient-specific therapies. The market is further driven by the increasing spending on research and development (R&D). This influx of funding drives innovation which in turn results in HTS technologies with enhanced and improved automation, miniaturization, and data analysis abilities. These improvements mean shorter screening times, improved throughput, and better data accuracy - making HTS a more beneficial approach for drug discovery teams.
It also benefits from feedback loops and rapid technological increases. The ultimate advantage of using automation is that it makes your screening much faster and streamlined, reducing the answer to time lag lets then human mistakes. Emerging miniaturization approaches have enabled researchers to develop even smaller, more portable HTS instruments benefiting a large scope of research groups and at the same time decreasing some of the large space demands for fully functioning HTS facilities. Lastly, advancements in data analysis enable the rapid assessment and interpretation of extensive datasets resulting from HTS experiments to better inform key decisions while uncovering elusive trends that have so far gone unnoticed but may be relevant.
Government support can then serve as a catalyst, driving more research and development into new technologies and facilitating connections between academia with industry. This in turn also helps to increase the availability of HTS capabilities for academic institutions. These drivers working in conjunction help form a future for the high-throughput screening market, which is more fluid and brighter than ever before - possibly disrupting drug discovery as we know it and making new medical breakthroughs possible.
MARKET DYNAMICS:
KEY DRIVERS:
Increasing Usage of High Throughput Screening Solutions in Universities and Research Centers is responsible for Market Growth.
The Open Access to High-throughput Screening Laboratories is Boosting the Market Growth.
RESTRAINTS:
The Need for Extensive Automation Techniques is Hindering High Throughput Screening Market Growth.
The High rate of Capital Investment Can Limit the Growth of High Throughput Screening.
OPPORTUNITY:
Technological Advancements are Offering a Lucrative Growth Opportunity for High Throughput Screening Procedures.
Hefty R&D Investments are Responsible for the Market Growth During Upcoming Years.
In 2023, cell-based assays acquired over 45.0% of the overall revenue. Visible results by fluorometric imaging plate reader assays followed by cell-based assays along with the least volume for testing have outperformed other cell-based assays. Ultra-high throughput screening is the most recent technology development that is used for increased output in less time. Most of the companies are at an intermediate level where they use 3-D cells along with conventional cell culture techniques, this is because in itself 3-D cells provide less realistic properties to screen drugs in a natural environment and other cellular assays which used to help in drug designing and discovery.
Various such steps like the exploration of the capacity of chemical libraries for identifying chemical identity hits proactively while testing, hardware and software testing capacity and fully automated, increased funding from governments and research institutes to adopt newer technologies and faster data processing software are expected to boost the market.
Get Customized Report as per your Business Requirement - Request For Customized Report
Organizations of pharmaceutical and biotech firms accounted maximum share in the high-throughput screening market which is 41% in 2023. Furthermore, the increasing demand for quick and accurate screening for multi-target molecules at drug discovery stages has led to using automated high-throughput screening tools that screen large chemical libraries or biomarker libraries created during research activities.
In addition, a study released in June 2020 titled "Large-scale screening of fresh drugs" showed that fluorescence-based assays are effective for detecting biological responses to chemical substances under high-throughput conditions. Furthermore, a target molecule may be produced or depleted in fluorescence experiments to cause signals outgassing and quenching according to the same source. Post which, a boost in the utilization of high-throughput screening methods for drug discovery is foreseen to influence market expansion.
Primary screening dominated in 2023 with a share of 38%. The reason for this dominance seems to lie in the sheer volume of testing. The potential candidates for drugs in the thousands are separated by primary screening, and this volume work is best handled using reagents and kits that were meant to be used with automation. In contrast, the standardization of protocols and optimization of reagents within kits not only guarantees consistency but also reduces any variability - a requirement when analyzing thousands (or millions) of samples. Lastly, cost is a major factor during primary screening as this phase aims to find potential leads. The use of pre-formatted reagents and kits is more cost-effective than developing/sure-routing custom experiments that must be run for each candidate. Primary screening - which includes high-throughput approaches, standardization efforts, and cost-saving design over target identification or toxicology testing stands out in reagent/kit consumption relevant to drug discovery.
North America held 44% of market revenue in 2023. Factors attributing to North America's largest market share include the growing adoption of high-throughput screening, increases in research and development expenditure on pharmaceuticals by governments & NGOs worldwide leading to boosts in combinatorial chemistry as well as genomics advances, significant investments made towards automation miniaturization assay methodology for HTS technologies across their labs grow further.
This high spending of pharmaceutical companies and several government organizations on research & development (R&D) is expected to offer a good market outlook in the upcoming years. For example, Danaher Corporation spent USD 1.742 million on R&D at the fiscal year-end of 2021) versus (the fiscal year-end of 2020 which amounted toUSD3475million). Also, Bio-Rad Laboratories Inc. pumped USD 879.6 million into the market in 2021 versus USD 800.3 million of investments from years earlier Therefore, the massive investment by the pharmaceutical industry is likely to boost market growth over the coming few years.
The key market players include PerkinElmer Inc., Bio-Rad Laboratories Inc., Axxam SpA, Beckman Coulter Inc., Merck KGaA, Tecan Group Ltd, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GE Healthcare, Danaher Corporation & other players.
Molbio Diagnostics introduced a novel test for differential diagnosis of HIV 1 and HIV 2 with viral loads in <60 min during August 2022.
Opera, a cell analyzer for rapid high-content analysis of drug action at even sub-cellular resolution was unveiled by Evotech Technologies in July 2022.
| Report Attributes | Details |
| Market Size in 2023 | US$ 25.80 Billion |
| Market Size by 2032 | US$ 69.46 Billion |
| CAGR | CAGR of 12.18% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Technology (Ultra-high-throughput Screening, Cell-based Assays, Lab-on-a-chip and Label-free Technology) •By Application (Target Identification, Primary Screening, and Toxicology) •By Products and Services (Instruments, Reagents, and Kits, and Services) •By End User (Pharmaceutical and Biotechnology Firms, Academia and Research Institutes and Contract Research Organizations) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | PerkinElmer Inc., Bio-Rad Laboratories Inc., Axxam SpA, Beckman Coulter Inc., Merck KGaA, Tecan Group Ltd, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GE Healthcare, Danaher Corporation & other players |
| Key Drivers | •Increasing Usage of High Throughput Screening Solutions in Universities and Research Centers is responsible for Market Growth. •The Open Access to High-throughput Screening Laboratories is Boosting the Market Growth. |
| RESTRAINTS | •The Need for Extensive Automation Techniques is Hindering High Throughput Screening Market Growth. •The High rate of Capital Investment Can Limit the Growth of High Throughput Screening. |
Ans: The U.S. led the High Throughput Screening in the North American region with the highest revenue share in 2023.
Ans: Factors such as the Need for Extensive Automation Techniques & the High rate of Capital Investment Can Limit the Growth of the High Throughput Screening market.
Ans: Cell-based Assays will increase in the High Throughput Screening Market from 2024-2032.
Ans: The expected CAGR of the Global High Throughput Screening Market during the forecast period is 12.18%.
Ans: The High Throughput Screening Market was valued at USD 25.80 billion in 2023.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. High Throughput Screening Market Segmentation, By Technology
7.1 Introduction
7.2 Ultra-high-throughput Screening
7.3 Cell-based Assays
7.4 Lab-on-a-chip
7.5 Label-free Technology
8. High Throughput Screening Market Segmentation, By Application
8.1 Introduction
8.2 Target Identification
8.3 Primary Screening
8.4 Toxicology
9. High Throughput Screening Market Segmentation, By Products and Services
9.1 Introduction
9.2 Instruments
9.3 Reagents, and Kits
9.4 Services
10. High Throughput Screening Market Segmentation, By End User
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Firms
10.3 Academia and Research Institutes
10.4 Contract Research Organizations
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 Trend Analysis
11.2.2 North America High Throughput Screening Market by Country
11.2.3 North America High Throughput Screening Market By Technology
11.2.4 North America High Throughput Screening Market By Application
11.2.5 North America High Throughput Screening Market By Products and Services
11.2.6 North America High Throughput Screening Market By End User
11.2.7 USA
11.2.7.1 USA High Throughput Screening Market By Technology
11.2.7.2 USA High Throughput Screening Market By Application
11.2.7.3 USA High Throughput Screening Market By Products and Services
11.2.7.4 USA High Throughput Screening Market By End User
11.2.8 Canada
11.2.8.1 Canada High Throughput Screening Market By Technology
11.2.8.2 Canada High Throughput Screening Market By Application
11.2.8.3 Canada High Throughput Screening Market By Products and Services
11.2.8.4 Canada High Throughput Screening Market By End User
11.2.9 Mexico
11.2.9.1 Mexico High Throughput Screening Market By Technology
11.2.9.2 Mexico High Throughput Screening Market By Application
11.2.9.3 Mexico High Throughput Screening Market By Products and Services
11.2.9.4 Mexico High Throughput Screening Market By End User
11.3 Europe
11.3.1 Trend Analysis
11.3.2 Eastern Europe
11.3.2.1 Eastern Europe High Throughput Screening Market by Country
11.3.2.2 Eastern Europe High Throughput Screening Market By Technology
11.3.2.3 Eastern Europe High Throughput Screening Market By Application
11.3.2.4 Eastern Europe High Throughput Screening Market By Products and Services
11.3.2.5 Eastern Europe High Throughput Screening Market By End User
11.3.2.6 Poland
11.3.2.6.1 Poland High Throughput Screening Market By Technology
11.3.2.6.2 Poland High Throughput Screening Market By Application
11.3.2.6.3 Poland High Throughput Screening Market By Products and Services
11.3.2.6.4 Poland High Throughput Screening Market By End User
11.3.2.7 Romania
11.3.2.7.1 Romania High Throughput Screening Market By Technology
11.3.2.7.2 Romania High Throughput Screening Market By Application
11.3.2.7.3 Romania High Throughput Screening Market By Products and Services
11.3.2.7.4 Romania High Throughput Screening Market By End User
11.3.2.8 Hungary
11.3.2.8.1 Hungary High Throughput Screening Market By Technology
11.3.2.8.2 Hungary High Throughput Screening Market By Application
11.3.2.8.3 Hungary High Throughput Screening Market By Products and Services
11.3.2.8.4 Hungary High Throughput Screening Market By End User
11.3.2.9 Turkey
11.3.2.9.1 Turkey High Throughput Screening Market By Technology
11.3.2.9.2 Turkey High Throughput Screening Market By Application
11.3.2.9.3 Turkey High Throughput Screening Market By Products and Services
11.3.2.9.4 Turkey High Throughput Screening Market By End User
11.3.2.10 Rest of Eastern Europe
11.3.2.10.1 Rest of Eastern Europe High Throughput Screening Market By Technology
11.3.2.10.2 Rest of Eastern Europe High Throughput Screening Market By Application
11.3.2.10.3 Rest of Eastern Europe High Throughput Screening Market By Products and Services
11.3.2.10.4 Rest of Eastern Europe High Throughput Screening Market By End User
11.3.3 Western Europe
11.3.3.1 Western Europe High Throughput Screening Market by Country
11.3.3.2 Western Europe High Throughput Screening Market By Technology
11.3.3.3 Western Europe High Throughput Screening Market By Application
11.3.3.4 Western Europe High Throughput Screening Market By Products and Services
11.3.3.5 Western Europe High Throughput Screening Market By End User
11.3.3.6 Germany
11.3.3.6.1 Germany High Throughput Screening Market By Technology
11.3.3.6.2 Germany High Throughput Screening Market By Application
11.3.3.6.3 Germany High Throughput Screening Market By Products and Services
11.3.3.6.4 Germany High Throughput Screening Market By End User
11.3.3.7 France
11.3.3.7.1 France High Throughput Screening Market By Technology
11.3.3.7.2 France High Throughput Screening Market By Application
11.3.3.7.3 France High Throughput Screening Market By Products and Services
11.3.3.7.4 France High Throughput Screening Market By End User
11.3.3.8 UK
11.3.3.8.1 UK High Throughput Screening Market By Technology
11.3.3.8.2 UK High Throughput Screening Market By Application
11.3.3.8.3 UK High Throughput Screening Market By Products and Services
11.3.3.8.4 UK High Throughput Screening Market By End User
11.3.3.9 Italy
11.3.3.9.1 Italy High Throughput Screening Market By Technology
11.3.3.9.2 Italy High Throughput Screening Market By Application
11.3.3.9.3 Italy High Throughput Screening Market By Products and Services
11.3.3.9.4 Italy High Throughput Screening Market By End User
11.3.3.10 Spain
11.3.3.10.1 Spain High Throughput Screening Market By Technology
11.3.3.10.2 Spain High Throughput Screening Market By Application
11.3.3.10.3 Spain High Throughput Screening Market By Products and Services
11.3.3.10.4 Spain High Throughput Screening Market By End User
11.3.3.11 Netherlands
11.3.3.11.1 Netherlands High Throughput Screening Market By Technology
11.3.3.11.2 Netherlands High Throughput Screening Market By Application
11.3.3.11.3 Netherlands High Throughput Screening Market By Products and Services
11.3.3.11.4 Netherlands High Throughput Screening Market By End User
11.3.3.12 Switzerland
11.3.3.12.1 Switzerland High Throughput Screening Market By Technology
11.3.3.12.2 Switzerland High Throughput Screening Market By Application
11.3.3.12.3 Switzerland High Throughput Screening Market By Products and Services
11.3.3.12.4 Switzerland High Throughput Screening Market By End User
11.3.3.13 Austria
11.3.3.13.1 Austria High Throughput Screening Market By Technology
11.3.3.13.2 Austria High Throughput Screening Market By Application
11.3.3.13.3 Austria High Throughput Screening Market By Products and Services
11.3.3.13.4 Austria High Throughput Screening Market By End User
11.3.3.14 Rest of Western Europe
11.3.3.14.1 Rest of Western Europe High Throughput Screening Market By Technology
11.3.3.14.2 Rest of Western Europe High Throughput Screening Market By Application
11.3.3.14.3 Rest of Western Europe High Throughput Screening Market By Products and Services
11.3.3.14.4 Rest of Western Europe High Throughput Screening Market By End User
11.4 Asia-Pacific
11.4.1 Trend Analysis
11.4.2 Asia-Pacific High Throughput Screening Market by Country
11.4.3 Asia-Pacific High Throughput Screening Market By Technology
11.4.4 Asia-Pacific High Throughput Screening Market By Application
11.4.5 Asia-Pacific High Throughput Screening Market By Products and Services
11.4.6 Asia-Pacific High Throughput Screening Market By End User
11.4.7 China
11.4.7.1 China High Throughput Screening Market By Technology
11.4.7.2 China High Throughput Screening Market By Application
11.4.7.3 China High Throughput Screening Market By Products and Services
11.4.7.4 China High Throughput Screening Market By End User
11.4.8 India
11.4.8.1 India High Throughput Screening Market By Technology
11.4.8.2 India High Throughput Screening Market By Application
11.4.8.3 India High Throughput Screening Market By Products and Services
11.4.8.4 India High Throughput Screening Market By End User
11.4.9 Japan
11.4.9.1 Japan High Throughput Screening Market By Technology
11.4.9.2 Japan High Throughput Screening Market By Application
11.4.9.3 Japan High Throughput Screening Market By Products and Services
11.4.9.4 Japan High Throughput Screening Market By End User
11.4.10 South Korea
11.4.10.1 South Korea High Throughput Screening Market By Technology
11.4.10.2 South Korea High Throughput Screening Market By Application
11.4.10.3 South Korea High Throughput Screening Market By Products and Services
11.4.10.4 South Korea High Throughput Screening Market By End User
11.4.11 Vietnam
11.4.11.1 Vietnam High Throughput Screening Market By Technology
11.4.11.2 Vietnam High Throughput Screening Market By Application
11.4.11.3 Vietnam High Throughput Screening Market By Products and Services
11.4.11.4 Vietnam High Throughput Screening Market By End User
11.4.12 Singapore
11.4.12.1 Singapore High Throughput Screening Market By Technology
11.4.12.2 Singapore High Throughput Screening Market By Application
11.4.12.3 Singapore High Throughput Screening Market By Products and Services
11.4.12.4 Singapore High Throughput Screening Market By End User
11.4.13 Australia
11.4.13.1 Australia High Throughput Screening Market By Technology
11.4.13.2 Australia High Throughput Screening Market By Application
11.4.13.3 Australia High Throughput Screening Market By Products and Services
11.4.13.4 Australia High Throughput Screening Market By End User
11.4.14 Rest of Asia-Pacific
11.4.14.1 Rest of Asia-Pacific High Throughput Screening Market By Technology
11.4.14.2 Rest of Asia-Pacific High Throughput Screening Market By Application
11.4.14.3 Rest of Asia-Pacific High Throughput Screening Market By Products and Services
11.4.14.4 Rest of Asia-Pacific High Throughput Screening Market By End User
11.5 Middle East & Africa
11.5.1 Trend Analysis
11.5.2 Middle East
11.5.2.1 Middle East High Throughput Screening Market by Country
11.5.2.2 Middle East High Throughput Screening Market By Technology
11.5.2.3 Middle East High Throughput Screening Market By Application
11.5.2.4 Middle East High Throughput Screening Market By Products and Services
11.5.2.5 Middle East High Throughput Screening Market By End User
11.5.2.6 UAE
11.5.2.6.1 UAE High Throughput Screening Market By Technology
11.5.2.6.2 UAE High Throughput Screening Market By Application
11.5.2.6.3 UAE High Throughput Screening Market By Products and Services
11.5.2.6.4 UAE High Throughput Screening Market By End User
11.5.2.7 Egypt
11.5.2.7.1 Egypt High Throughput Screening Market By Technology
11.5.2.7.2 Egypt High Throughput Screening Market By Application
11.5.2.7.3 Egypt High Throughput Screening Market By Products and Services
11.5.2.7.4 Egypt High Throughput Screening Market By End User
11.5.2.8 Saudi Arabia
11.5.2.8.1 Saudi Arabia High Throughput Screening Market By Technology
11.5.2.8.2 Saudi Arabia High Throughput Screening Market By Application
11.5.2.8.3 Saudi Arabia High Throughput Screening Market By Products and Services
11.5.2.8.4 Saudi Arabia High Throughput Screening Market By End User
11.5.2.9 Qatar
11.5.2.9.1 Qatar High Throughput Screening Market By Technology
11.5.2.9.2 Qatar High Throughput Screening Market By Application
11.5.2.9.3 Qatar High Throughput Screening Market By Products and Services
11.5.2.9.4 Qatar High Throughput Screening Market By End User
11.5.2.10 Rest of Middle East
11.5.2.10.1 Rest of Middle East High Throughput Screening Market By Technology
11.5.2.10.2 Rest of Middle East High Throughput Screening Market By Application
11.5.2.10.3 Rest of Middle East High Throughput Screening Market By Products and Services
11.5.2.10.4 Rest of Middle East High Throughput Screening Market By End User
11.5.3 Africa
11.5.3.1 Africa High Throughput Screening Market by Country
11.5.3.2 Africa High Throughput Screening Market By Technology
11.5.3.3 Africa High Throughput Screening Market By Application
11.5.3.4 Africa High Throughput Screening Market By Products and Services
11.5.3.5 Africa High Throughput Screening Market By End User
11.5.3.6 Nigeria
11.5.3.6.1 Nigeria High Throughput Screening Market By Technology
11.5.3.6.2 Nigeria High Throughput Screening Market By Application
11.5.3.6.3 Nigeria High Throughput Screening Market By Products and Services
11.5.3.6.4 Nigeria High Throughput Screening Market By End User
11.5.3.7 South Africa
11.5.3.7.1 South Africa High Throughput Screening Market By Technology
11.5.3.7.2 South Africa High Throughput Screening Market By Application
11.5.3.7.3 South Africa High Throughput Screening Market By Products and Services
11.5.3.7.4 South Africa High Throughput Screening Market By End User
11.5.3.8 Rest of Africa
11.5.3.8.1 Rest of Africa High Throughput Screening Market By Technology
11.5.3.8.2 Rest of Africa High Throughput Screening Market By Application
11.5.3.8.3 Rest of Africa High Throughput Screening Market By Products and Services
11.5.3.8.4 Rest of Africa High Throughput Screening Market By End User
11.6 Latin America
11.6.1 Trend Analysis
11.6.2 Latin America High Throughput Screening Market by Country
11.6.3 Latin America High Throughput Screening Market By Technology
11.6.4 Latin America High Throughput Screening Market By Application
11.6.5 Latin America High Throughput Screening Market By Products and Services
11.6.6 Latin America High Throughput Screening Market By End User
11.6.7 Brazil
11.6.7.1 Brazil High Throughput Screening Market By Technology
11.6.7.2 Brazil High Throughput Screening Market By Application
11.6.7.3 Brazil High Throughput Screening Market By Products and Services
11.6.7.4 Brazil High Throughput Screening Market By End User
11.6.8 Argentina
11.6.8.1 Argentina High Throughput Screening Market By Technology
11.6.8.2 Argentina High Throughput Screening Market By Application
11.6.8.3 Argentina High Throughput Screening Market By Products and Services
11.6.8.4 Argentina High Throughput Screening Market By End User
11.6.9 Colombia
11.6.9.1 Colombia High Throughput Screening Market By Technology
11.6.9.2 Colombia High Throughput Screening Market By Application
11.6.9.3 Colombia High Throughput Screening Market By Products and Services
11.6.9.4 Colombia High Throughput Screening Market By End User
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America High Throughput Screening Market By Technology
11.6.10.2 Rest of Latin America High Throughput Screening Market By Application
11.6.10.3 Rest of Latin America High Throughput Screening Market By Products and Services
11.6.10.4 Rest of Latin America High Throughput Screening Market By End User
12. Company Profiles
12.1 PerkinElmer Inc.
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 The SNS View
12.2 Bio-Rad Laboratories Inc.
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 The SNS View
12.3 Axxam SpA
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 The SNS View
12.4 Beckman Coulter Inc.
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 The SNS View
12.5 Merck KGaA
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 The SNS View
12.6 Tecan Group Ltd.
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 The SNS View
12.7 Agilent Technologies Inc.
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 The SNS View
12.8 Thermo Fisher Scientific Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 The SNS View
12.9 GE Healthcare
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 The SNS View
12.10 Danaher Corporation
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Technology
Ultra-high-throughput Screening
Cell-based Assays
Lab-on-a-chip
Label-free Technology
By Application
Target Identification
Primary Screening
Toxicology
By Products and Services
Instruments
Reagents, and Kits
Services
By End User
Pharmaceutical and Biotechnology Firms
Academia and Research Institutes
Contract Research Organizations
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
• With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
• Product Analysis
• Criss-Cross segment analysis (e.g. Product X Application)
• Product Matrix which gives a detailed comparison of product portfolio of each company
• Geographic Analysis
• Additional countries in any of the regions
• Company Information
• Detailed analysis and profiling of additional market players (Up to five)
The Retinal Biologics Market Size was valued at USD 22.5 Billion in 2023 and is expected to reach USD 49.5 Billion by 2032 and grow at a CAGR of 9.2% over the forecast period 2024-2032.
The Peptide Microarray Market size was estimated at USD 830.83 million in 2023 and is expected to reach USD 1245.37 million by 2032 with a growing CAGR of 4.6% during the forecast period of 2024-2032.
The Biotech CRO Market Size was valued at USD 68.14 billion in 2023 and is will each USD 114.46 billion by 2032, growing at a CAGR of 5.9% from 2024-2032.
The Pregnancy Pillow Market was estimated at USD 0.67 Billion in 2023 and is poised to reach at 0.862 billion in 2031 anticipated to expand at a compound annual growth rate approx. CAGR of 3.2% for the forecast period of 2024-2031.
The Multiple Sclerosis (MS) Market size was valued at USD 21.5 billion in 2023 and is expected to reach USD 39.20 billion by 2031 and grow at a CAGR of 7.8% over the forecast period of 2024-2031.
The Advanced Visualization Market was valued at USD 3.64 Billion in 2023 and it is projected to reach USD 9.77 Billion by 2032, registering a compound annual growth rate (CAGR) of 11.6% from 2024 to 2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
